http://www.stem-cells-news.com/1/2009/09/pluristembegins-enrollment-in-u-s-with-unmatched-placenta-derived-stem-cell-product-plx-pad-in-a-phase-i-clinical-trial-for-treatment-of-peripheral-artery-disease/ news from the world about stem cells Wed, 11 Jan 2012 16:46:40 +0000 hourly 1 http://www.stem-cells-news.com/1/2009/09/pluristembegins-enrollment-in-u-s-with-unmatched-placenta-derived-stem-cell-product-plx-pad-in-a-phase-i-clinical-trial-for-treatment-of-peripheral-artery-disease/#comment-592 Neuralstem gets FDA OK for Stem cell trial for ALS treatment « Stem Cell News Sat, 26 Sep 2009 06:58:05 +0000 http://www.stem-cells-news.com/1/?p=677#comment-592 [...] PluristemBegins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Ph...Pluristem Therapeutics Inc. today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company`s [...] [...] PluristemBegins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Ph…Pluristem Therapeutics Inc. today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company`s [...]

]]> http://www.stem-cells-news.com/1/2009/09/pluristembegins-enrollment-in-u-s-with-unmatched-placenta-derived-stem-cell-product-plx-pad-in-a-phase-i-clinical-trial-for-treatment-of-peripheral-artery-disease/#comment-575 First Stem Cell Drug Fails 2 Late-Stage Clinical Trials « Stem Cell News Sat, 12 Sep 2009 05:08:20 +0000 http://www.stem-cells-news.com/1/?p=677#comment-575 [...] PluristemBegins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Ph...Pluristem Therapeutics Inc. today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company`s [...] [...] PluristemBegins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Ph…Pluristem Therapeutics Inc. today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company`s [...]

]]>